These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate). Mukherjee J, Kamnasaran D, Balasubramaniam A, Radovanovic I, Zadeh G, Kiehl TR, Guha A. Cancer Res; 2009 Jun 15; 69(12):5099-107. PubMed ID: 19509233 [Abstract] [Full Text] [Related]
7. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE, Salgia R. Oncogene; 2000 Jul 20; 19(31):3521-8. PubMed ID: 10918610 [Abstract] [Full Text] [Related]
15. Potential role of imatinib mesylate (Gleevec, STI-571) in the treatment of vestibular schwannoma. Altuna X, Lopez JP, Yu MA, Arandazi MJ, Harris JP, Wang-Rodriguez J, An Y, Dobrow R, Doherty JK, Ongkeko WM. Otol Neurotol; 2011 Jan 01; 32(1):163-70. PubMed ID: 21157293 [Abstract] [Full Text] [Related]
16. Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec). Ivan D, Niveiro M, Diwan AH, Eton O, Kim KB, Lacey C, Gonzalez C, Prieto VG. J Cutan Pathol; 2006 Apr 01; 33(4):280-5. PubMed ID: 16630177 [Abstract] [Full Text] [Related]
17. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells. Ren H, Tan X, Dong Y, Giese A, Chou TC, Rainov N, Yang B. Basic Clin Pharmacol Toxicol; 2009 Mar 01; 104(3):241-52. PubMed ID: 19159435 [Abstract] [Full Text] [Related]
18. Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo. Irsan I, Akisue T, Hara H, Fujimoto T, Imabori M, Doita M, Kuroda R, Fujioka H, Kawamoto T, Yamamoto T, Kurosaka M. Anticancer Res; 2007 Mar 01; 27(1A):423-9. PubMed ID: 17352263 [Abstract] [Full Text] [Related]
19. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity. Basciani S, Brama M, Mariani S, De Luca G, Arizzi M, Vesci L, Pisano C, Dolci S, Spera G, Gnessi L. Cancer Res; 2005 Mar 01; 65(5):1897-903. PubMed ID: 15753388 [Abstract] [Full Text] [Related]
20. Effects of STI571 (gleevec) on pancreatic cancer cell growth. Li J, Kleeff J, Guo J, Fischer L, Giese N, Büchler MW, Friess H. Mol Cancer; 2003 Sep 17; 2():32. PubMed ID: 14521721 [Abstract] [Full Text] [Related] Page: [Next] [New Search]